These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14523271)

  • 21. HIV-1 env, nef, and gag-specific T-cell immunity in mice: conserved epitopes in nef p27 and gag p25 proteins.
    Michel F; Hoffenbach A; Froussard P; Langlade-Demoyen P; Kaczorek M; Kieny MP; Plata F
    AIDS Res Hum Retroviruses; 1992 Apr; 8(4):469-78. PubMed ID: 1376136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD8+ T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses.
    Arrode G; Finke JS; Zebroski H; Siegal FP; Steinman RM
    Eur J Immunol; 2005 Jan; 35(1):159-70. PubMed ID: 15580653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 MN Env 15-mer peptides better detect HIV-1 specific CD8 T cell responses compared with consensus subtypes B and M group 15-mer peptides.
    Rutebemberwa A; Currier JR; Jagodzinski L; McCutchan F; Birx D; Marovich M; Cox JH
    AIDS; 2005 Jul; 19(11):1165-72. PubMed ID: 15990569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher cross-subtype IFN-γ ELISpot responses to Gag and Nef peptides in Brazilian HIV-1 subtype B- and F1- than in C-infected subjects.
    Côrtes FH; Bello G; Vorsatz C; Pilotto JH; Guimarães ML; Grinsztejn B; Veloso VG; Pinto AR; Morgado MG
    Vaccine; 2013 Feb; 31(7):1106-12. PubMed ID: 23261042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.
    Zheng NN; Kiviat NB; Sow PS; Hawes SE; Wilson A; Diallo-Agne H; Critchlow CW; Gottlieb GS; Musey L; McElrath MJ
    J Virol; 2004 Dec; 78(24):13934-42. PubMed ID: 15564501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal antigens for HIV vaccines based on CD8+ T response, protein length, and sequence variability.
    Betts MR; Yusim K; Koup RA
    DNA Cell Biol; 2002 Sep; 21(9):665-70. PubMed ID: 12396609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes.
    Lubaki MN; Egan MA; Siliciano RF; Weinhold KJ; Bollinger RC
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1427-31. PubMed ID: 7888197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.
    Malm M; Rollman E; Ustav M; Hinkula J; Krohn K; Wahren B; Blazevic V
    Viral Immunol; 2005; 18(4):678-88. PubMed ID: 16359234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
    Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
    AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection.
    Shankar P; Russo M; Harnisch B; Patterson M; Skolnik P; Lieberman J
    Blood; 2000 Nov; 96(9):3094-101. PubMed ID: 11049989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection.
    Eller MA; Eller LA; Ratto-Kim S; Ouma BJ; Lo V; de Souza M; Guwatudde D; Nails B; Michael NL; Wabwire-Mangen F; Robb ML; Marovich MA; Sandberg JK; Currier JR
    J Acquir Immune Defic Syndr; 2012 Sep; 61(1):9-18. PubMed ID: 22580564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of cellular immune responses in subjects chronically infected with HIV type 1.
    Fu TM; Dubey SA; Mehrotra DV; Freed DC; Trigona WL; Adams-Muhler L; Clair JH; Evans TG; Steigbigel R; Jacobson JM; Goepfert PA; Mulligan MJ; Kalams SA; Rinaldo C; Zhu L; Cox KS; Guan L; Long R; Persaud N; Caulfield MJ; Sadoff JC; Emini EA; Thaler S; Shiver JW
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):67-76. PubMed ID: 17263635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human immunodeficiency virus-specific responses in adult Ugandans: patterns of cross-clade recognition.
    Barugahare B; Baker C; K'Aluoch O; Donovan R; Elrefaei M; Eggena M; Jones N; Mutalya S; Kityo C; Mugyenyi P; Cao H
    J Virol; 2005 Apr; 79(7):4132-9. PubMed ID: 15767414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection.
    Draenert R; Verrill CL; Tang Y; Allen TM; Wurcel AG; Boczanowski M; Lechner A; Kim AY; Suscovich T; Brown NV; Addo MM; Walker BD
    J Virol; 2004 Jan; 78(2):630-41. PubMed ID: 14694094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
    Carmichael A; Jin X; Sissons P; Borysiewicz L
    J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited immunogenicity of HIV CD8+ T-cell epitopes in acute Clade C virus infection.
    Radebe M; Nair K; Chonco F; Bishop K; Wright JK; van der Stok M; Bassett IV; Mncube Z; Altfeld M; Walker BD; Ndung'u T
    J Infect Dis; 2011 Sep; 204(5):768-76. PubMed ID: 21844303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection.
    Critchfield JW; Lemongello D; Walker DH; Garcia JC; Asmuth DM; Pollard RB; Shacklett BL
    J Virol; 2007 Jun; 81(11):5460-71. PubMed ID: 17344302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand.
    Sriwanthana B; Hodge T; Mastro TD; Dezzutti CS; Bond K; Stephens HA; Kostrikis LG; Limpakarnjanarat K; Young NL; Qari SH; Lal RB; Chandanayingyong D; McNicholl JM
    AIDS Res Hum Retroviruses; 2001 May; 17(8):719-34. PubMed ID: 11429112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dominant ex vivo cross-stimulation of CD8+ T-cells with whole soluble gag protein in HIV-infected subjects.
    Tavernier A; Jennes W; Fransen K; De Roo A; Kestens L
    J Acquir Immune Defic Syndr; 2006 Apr; 41(5):548-56. PubMed ID: 16652028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection.
    Malhotra U; Li F; Nolin J; Allison M; Zhao H; Mullins JI; Self S; McElrath MJ
    J Virol; 2007 May; 81(10):5225-37. PubMed ID: 17329342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.